BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29545434)

  • 1. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer.
    Gouveia HS; Lopes SO; Faria AL
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Lysis Syndrome in a Patient With Gastric Adenocarcinoma.
    Lingamaneni P; Desai P; Vennikandam MM; Moturi K; Baranwal A; Gupta S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620933427. PubMed ID: 32536280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary Adenocarcinoma with Focal Choriocarcinomatous Differentiation in the Sigmoid Colon.
    Oh SK; Kim HW; Kang DH; Choi CW; Choi YY; Lim HK; Goo JJ; Choi SY
    Korean J Gastroenterol; 2015 Nov; 66(5):291-6. PubMed ID: 26586354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver metastasis from colonic adenocarcinoma presenting as nephrolithiasis: computed tomography findings.
    Abu-Ghanem S; Novik EF; Abu-Ghanem Y; Man S; Shelef I
    Isr Med Assoc J; 2011 Oct; 13(10):638-9. PubMed ID: 22097237
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of vinegar to relieve persistent hiccups in an advanced cancer patient.
    Gonella S; Gonella F
    J Palliat Med; 2015 May; 18(5):467-70. PubMed ID: 25775370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
    Taieb J; Tabernero J; Mini E; Subtil F; Folprecht G; Van Laethem JL; Thaler J; Bridgewater J; Petersen LN; Blons H; Collette L; Van Cutsem E; Rougier P; Salazar R; Bedenne L; Emile JF; Laurent-Puig P; Lepage C;
    Lancet Oncol; 2014 Jul; 15(8):862-73. PubMed ID: 24928083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.
    Malkhasyan K; Halene S; Lacy J
    Clin Colorectal Cancer; 2015 Mar; 14(1):e9-e12. PubMed ID: 25446051
    [No Abstract]   [Full Text] [Related]  

  • 10. [FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].
    Yan D; Dai H
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):217-9. PubMed ID: 19615264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.
    Angitapalli R; Litwin AM; Kumar PR; Nasser E; Lombardo J; Mashtare T; Wilding GE; Fakih MG
    Oncology; 2009; 76(5):363-8. PubMed ID: 19321964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of antivascular drugs after anti-EFGR: aflibercept after cetuximab, a clinical case].
    Aroldi F; Zaniboni A
    Recenti Prog Med; 2015 Dec; 106(12):653e-6e. PubMed ID: 26780078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.
    Zichi C; Tampellini M; Tucci M; Sonetto C; Baratelli C; Brizzi MP; Scagliotti GV
    BMC Cancer; 2018 Apr; 18(1):470. PubMed ID: 29699528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.
    Grenader T; Goldberg A; Gabizon A
    Anticancer Drugs; 2009 Oct; 20(9):845-7. PubMed ID: 19633535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer.
    Uehara K; Ishiguro S; Hiramatsu K; Nishio H; Takeuchi E; Takahari D; Yoshioka Y; Takahashi Y; Ebata T; Yoshimura K; Muro K; Nagino M
    Jpn J Clin Oncol; 2011 Oct; 41(10):1229-32. PubMed ID: 21840871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan.
    Oztop I; Demirkan B; Yaren A; Tarhan O; Sengul B; Ulukus C; Akin D; Sen M; Yilmaz U; Alakavuklar M
    Tumori; 2004; 90(5):514-6. PubMed ID: 15656341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor lysis syndrome after FOLFIRI+cetuximab for ascending colon cancer].
    Matsuyama S; Kuramoto T; Tanaka R; Hashiguchi K
    Nihon Shokakibyo Gakkai Zasshi; 2015 Apr; 112(4):714-20. PubMed ID: 25843460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour lysis syndrome: new therapeutic strategies and classification.
    Cairo MS; Bishop M
    Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
    Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of metastatic colorectal cancer suffering from hyperammonemic encephalopathy induced by 5-FU, continuously treated with FOLFOX therapy].
    Shoji H; Kuroki M; Hiramoto K; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1583-6. PubMed ID: 20716892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.